{"id":1034007,"date":"2026-08-31T01:16:16","date_gmt":"2026-08-31T01:16:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1034007\/"},"modified":"2026-08-31T01:16:16","modified_gmt":"2026-08-31T01:16:16","slug":"fda-approves-new-use-of-popular-diabetes-drug","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1034007\/","title":{"rendered":"FDA approves new use of popular diabetes drug"},"content":{"rendered":"<p class=\"text | article-text\">(CNN) &#8211; The Food and Drug Administration is expanding the use of the diabetes drug Mounjaro to help prevent heart attacks and strokes.<\/p>\n<p class=\"text | article-text\">The new approval of the drug, which is produced by Eli Lilly, applies to high-risk adults with type 2 diabetes.<\/p>\n<p class=\"text | article-text\">Lilly says Mounjaro reduced major cardiovascular events by an additional 8% compared to its older diabetes drug, Trulicity.<\/p>\n<p class=\"text | article-text\">The same medication is prescribed for weight loss under the name Zepbound.<\/p>\n<p class=\"text | article-text\">Eli Lilly researchers say they are now testing newer drugs that target even more hormones.<\/p>\n<p>Copyright 2026 CNN Newsource. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"(CNN) &#8211; The Food and Drug Administration is expanding the use of the diabetes drug Mounjaro to help&hellip;\n","protected":false},"author":3,"featured_media":1034008,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[3655,210,1060,1106,67,132,68,428],"class_list":["post-1034007","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-diabetes","tag-health","tag-medication","tag-mounjaro","tag-united-states","tag-unitedstates","tag-us","tag-weight-loss"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117187483321905743","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1034007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1034007"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1034007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1034008"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1034007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1034007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1034007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}